Hims & Hers Health Inc (NYSE:HIMS) shares traded unchanged at $14.55 on Wall Street last session.
HIMS stock price is now 14.42% away from the 50-day moving average and 63.60% away from the 200-day moving average. The market capitalization of the company currently stands at $3.12B.
With the price target of $20, Canaccord Genuity recently initiated with Buy rating for Hims & Hers Health Inc (NYSE: HIMS). On February 28, 2024, Imperial Capital Upgraded its previous ‘In-line’ rating to ‘Outperform’ on the stock keeping its target price maintained at $16, while ‘Leerink Partners’ rates the stock as ‘Market Perform’
In other news, Baird Melissa, Chief Operating Officer sold 11,751 shares of the company’s stock on Apr 08 ’24. The stock was sold for $173,254 at an average price of $14.74. Upon completion of the transaction, the Chief Operating Officer now directly owns 538,932 shares in the company, valued at $7.84 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 05 ’24, Chief Operating Officer Baird Melissa sold 11,751 shares of the business’s stock. A total of $171,372 was realized by selling the stock at an average price of $14.58. This leaves the insider owning 538,932 shares of the company worth $7.84 million. A total of 35.26% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $5.65 and a high of $17.16. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 3.00, and a quick ratio of 2.74. The fifty day moving average price for HIMS is $12.83 and a two-hundred day moving average price translates $8.92 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for Dec, 2023. According to the Household & Personal Products Company, earnings per share came in at $0.01, beating analysts’ expectations of -$0.02 by 0.03. This compares to -$0.05 EPS in the same period last year. The net profit margin was -2.70% and return on equity was -7.18% for HIMS. The company reported revenue of $246.62 million for the quarter, compared to $167.2 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 47.5 percent. For the current quarter, analysts expect HIMS to generate $270.5M in revenue.
